Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Tralau-Stewart

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|January 1, 2014
UK academic drug discoveryCathy Tralau-Stewart, Caroline M R Low, Nicola Marlin
Frontiers in Immunology|June 28, 2019
Structural Modification of the Antidepressant Mianserin Suggests That Its Anti-inflammatory Activity May Be Independent of 5-Hydroxytryptamine ReceptorsSandra Sacre, Albert Jaxa-Chamiec, Caroline M R Low, et al.
Nature Medicine|May 24, 2011
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancerGeorgios Giamas, Aleksandra Filipović, Jimmy Jacob, et al.
Cancer Cell|September 13, 2017
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 InhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Cancer Cell|October 15, 2014
Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|January 1, 2014
UK academic drug discoveryCathy Tralau-Stewart, Caroline M R Low, Nicola Marlin
Frontiers in Immunology|June 28, 2019
Structural Modification of the Antidepressant Mianserin Suggests That Its Anti-inflammatory Activity May Be Independent of 5-Hydroxytryptamine ReceptorsSandra Sacre, Albert Jaxa-Chamiec, Caroline M R Low, et al.
Nature Medicine|May 24, 2011
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancerGeorgios Giamas, Aleksandra Filipović, Jimmy Jacob, et al.
Cancer Cell|September 13, 2017
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 InhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Cancer Cell|October 15, 2014
Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitorsLaura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Pageof 1